News Releases

» Marinus Pharmaceuticals Adds Two Life Sciences Veterans to its Board of Directors
» Marinus Pharmaceuticals Raises $20 Million in Series B Financing
» Marinus Pharmaceuticals, Inc. Announces Positive Results of its Phase 2 Clinical Trial of Ganaxolone as Adjunctive Therapy in Adults with Partial Onset Seizures
» Marinus Pharmaceuticals, Inc., Completes Two Phase 2 Milestones for Ganaxolone in Epilepsy
» Marinus Pharmaceuticals Appoints John Krayacich as President and Chief Executive Officer
» Marinus Pharmaceuticals Initiates Phase IIb Study of Ganaxolone for Adult Partial Seizures
» Marinus Pharmaceuticals Initiates Phase IIb Study of Ganaxolone for Infantile Spasms
» Marinus Pharmaceuticals completes a $29.4 million Series A financing round

Events

2009 Marinus Calendar
Apr 25-May 2		American Academy of Neurology Annual Meeting - Seattle, WA
May 5-17		Tenth Anti-epileptic Drug Trials Conference - Coral Gables, FL
Jun 28-Jul 2		8th International Epilepsy Congress - Budapest, Hungary
Nov 5-8		Child Neurology Society Annual Meeting  - Santa Clara, CA
Dec 4-8		American Epilepsy Society - Boston, MA

If you’d like to meet the Marinus team at any of the events above please contact us at 203-315-5812.